Home » Reports » Broker Ratings » GlaxoSmithKline plc 12.8% Potential Upside Indicated by Jefferies International
broker ratings

GlaxoSmithKline plc 12.8% Potential Upside Indicated by Jefferies International

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Jefferies International. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 1900 GBX on its stock. This is indicating the analyst believes there is a potential upside of 12.8% from the opening price of 1685 GBX. Over the last 30 and 90 trading days the company share price has increased 25 points and increased 3 points respectively. The 52 week high for the stock is 1745.56 GBX while the 52 week low for the share price is 1363 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,647.70 GBX and the 200 Day Moving Average price is recorded at 1,620.08. There are currently 4,917,855,701 shares in issue with the average daily volume traded being 9,706,253. Market capitalisation for LON:GSK is £82,792,100,726 GBP.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!